The fifth installment of the NextGen Precision Health Discovery Series, titled “The Genomics Core at MU and NextGen Precision Health,” will be held virtually at noon on Tuesday, June 8. The speaker, Wes Warren, PhD, is a professor of Genomics at the University of Missouri Bond Life Sciences Center and he is an internationally recognized expert in comparative genomics.

In this webinar, Dr. Warren will explore how over the last 10 years, “next-generation” sequencing (NGS) has created a paradigm shift in biological examination of disease as the sequencing instrument has become the modern era digital microscope of investigation. As a central campus/system resource, the MU DNA Core facility promises to substantially increase the development of system-wide research networks and impact all levels of multi-disciplinary basic, biomedical and clinical research. Dr. Warren will discuss the MU Tier 1 sequencing initiative and more generally the power of sequencing to address all types of biological questions with varied starting points, including the use of single cell technology.

Register here for the June 8 webinar to receive a Zoom link.

The NextGen Precision Health Discovery Series provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities. The series consists of monthly lectures geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts.

Did you miss our other webinars? Watch playbacks.

The Office of Continuing Education at the MU School of Medicine designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity. The University of Missouri Sinclair School of Nursing is approved as a provider of nursing continuing professional development and nurses can receive up to 1.0 contact hour for all participants who view the live sessions in their entirety and complete the evaluation form.

CONFLICT OF INTEREST: All persons with influence over the content of this program have been asked to disclose relevant financial interests, in the past 12 months, that might have an impact. John Spertus, MD, a planning committee member, is a consultant for Jannsen, Bayer, Myokardia, Merck and Novartis, and receives research support from Abbott Vascular. No other speaker or planning committee member has a relevant financial interest.

For questions, please contact Mary Hindle, senior director of education programs, at hindlem@health.missouri.edu.